Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/116909
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Cost-effectiveness of laparoscopy as diagnostic tool before primary cytoreductive surgery in ovarian cancer
Author: van de Vrie, R.
van Meurs, H.
Rutten, M.
Naaktgeboren, C.
Opmeer, B.
Gaarenstroom, K.
van Gorp, T.
Ter Brugge, H.
Hofhuis, W.
Schreuder, H.
Arts, H.
Zusterzeel, P.
Pijnenborg, J.
van Haaften, M.
Engelen, M.
Boss, E.
Vos, M.
Gerestein, K.
Schutter, E.
Kenter, G.
et al.
Citation: Gynecologic Oncology, 2017; 146(3):449-456
Publisher: Elsevier
Issue Date: 2017
ISSN: 0090-8258
1095-6859
Statement of
Responsibility: 
Roelien van de Vrie, Hannah S. van Meurs, Marianne J. Rutten, Christiana A. Naaktgeboren, Brent C. Opmeer, Katja N. Gaarenstroom, Toon van Gorp, Henk G. Ter Brugge, Ward Hofhuis, Henk W.R. Schreuder, Henriette J.G. Arts, Petra L.M. Zusterzeel, Johanna M.A. Pijnenborg, Maarten van Haaften , Mirjam J.A. Engelen, Erik A. Boss, M. Caroline Vos, Kees G. Gerestein, Eltjo M.J. Schutter, Gemma G. Kenter, Patrick M.M. Bossuyt, Ben Willem Mol, Marrije R. Buist
Abstract: Objective: To evaluate the cost-effectiveness of a diagnostic laparoscopy prior to primary cytoreductive surgery to prevent futile primary cytoreductive surgery (i.e. leaving >1cm residual disease) in patients suspected of advanced stage ovarian cancer. Methods: An economic analysis was conducted alongside a randomized controlled trial in which patients suspected of advanced stage ovarian cancer who qualified for primary cytoreductive surgery were randomized to either laparoscopy or primary cytoreductive surgery. Direct medical costs from a health care perspective over a 6-month time horizon were analyzed. Health outcomes were expressed in quality-adjusted life-years (QALYs) and utility was based on patient's response to the EQ-5D questionnaires. We primarily focused on direct medical costs based on Dutch standard prices. Results: We studied 201 patients, of whom 102 were randomized to laparoscopy and 99 to primary cytoreductive surgery. No significant difference in QALYs (utility=0.01; 95% CI 0.006 to 0.02) was observed. Laparoscopy reduced the number of futile laparotomies from 39% to 10%, while its costs were € 1400 per intervention, making the overall costs of both strategies comparable (difference € -80 per patient (95% CI -470 to 300)). Findings were consistent across various sensitivity analyses. Conclusion: In patients with suspected advanced stage ovarian cancer, a diagnostic laparoscopy reduced the number of futile laparotomies, without increasing total direct medical health care costs, or adversely affecting complications or quality of life.
Keywords: Cost-effectiveness; ovarian cancer; diagnostic laparoscopy; cytoreductive surgery; quality of life
Rights: © 2017 Elsevier Inc. All rights reserved.
DOI: 10.1016/j.ygyno.2017.06.019
Appears in Collections:Aurora harvest 8
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.